Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in ... - 7thSpace Interactive (press release)
Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in ... 7thSpace Interactive (press release) Blood levels of total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C), and high density lipoprotein cholesterol were determined. Furthermore, the severity of CAD was assessed with the Gensini score system based on the ...
24% of men above 25 hypertensive - Times of India
24% of men above 25 hypertensive Times of India NEW DELHI: As many as 24% men and 22.6% women in India - aged 25 years and above - are suffering from high blood pressure ( BP). Over one in 10 men and women aged 25 years and above have high blood sugar. More women in India (2.5% of adults aged 20 ...
Amarin: Most Undervalued Name In Biotech? - Seeking Alpha
Amarin: Most Undervalued Name In Biotech? Seeking Alpha This cholesterol can become attached to arterial walls, leading to plaque buildup and heart disease. HDL: High-density lipoprotein cholesterol, or "good" cholesterol, packages and takes LDL out of your bloodstream. VLDL: Very low-density lipoprotein ...
BP and lipid tests in pharmacies could boost risk-factor control - TheHeart.Org
BP and lipid tests in pharmacies could boost risk-factor control TheHeart.Org London, UK - A campaign in pharmacies in Portugal to encourage customers to have their blood pressure and cholesterol measured in-store found that almost half of the people who participated had a high risk of developing a fatal cardiovascular event in ...
Many diabetics in region don't meet 'bad cholesterol' target: Study - Gulf Today
Many diabetics in region don't meet 'bad cholesterol' target: Study Gulf Today ... being treated for hyperlipidemia are not meeting their goals for the reduction of 'bad cholesterol' (LDL-C). In doing so, such patients ran an exponentially greater risk of heart attacks due to co-existence of diabetes and high cholesterol levels.
Technology and Risk Modification Crucial to Preventing Stroke from Striking - TopWireNews (press release)
Technology and Risk Modification Crucial to Preventing Stroke from Striking TopWireNews (press release) Hyperlipidemia (elevated cholesterol levels): About one in every six adults or 16.3 percent of the US adult population has high total cholesterol. Previous stroke: Of the 795000 annual cases, 185000 are recurrent attacks. Experiencing a previous stroke ...
New ESC cardiovascular disease guidelines emphasize primary prevention - TheHeart.Org
New ESC cardiovascular disease guidelines emphasize primary prevention TheHeart.Org Similarly, recommendations on the management of hyperlipidemia are unchanged from the previous guidelines, with LDL cholesterol remaining the primary treatment target. In patients at very high risk for cardiovascular disease, LDL-cholesterol levels ...
Carotech Inc. Launches NUTRITION Clinical Trial - Natural Products INSIDER
Carotech Inc. Launches NUTRITION Clinical Trial Natural Products INSIDER ... function and blood lipid profile including high-density lipoprotein (HDL), low-denisty lipoprotein LDL and total cholesterol. Volunteers (n=210) will be recruited and divided into two groups, Healthy (Phase I) and Hyperlipidemic (Phase II).
Stroke Does Not Discriminate ? Prevention Through Technology and Risk ... - Healthcare Global (press release)
Stroke Does Not Discriminate ? Prevention Through Technology and Risk ... Healthcare Global (press release) (Source: American Heart Association) Hyperlipidemia (elevated cholesterol levels): About one in every six adults or 16.3 percent of the US adult population has high total cholesterol. (Source: Centers for Disease Control and Prevention) Previous ...
A Rare, De-Risked Break-Out Stock For Healthcare Investors - Proactive Investors USA & Canada
A Rare, De-Risked Break-Out Stock For Healthcare Investors Proactive Investors USA & Canada Neptune shareholders have their own stake in the subsidiaries, Acasti Pharma (TSX:APO) and NeuroBioPharm-- each of which aim to demonstrate the therapeutic benefits for human conditions which include: Hyperlipidemia/ Cholesterol Management, ...
What our clients and candidates are saying about us: The website looks great. You truly are the best! - recruiter that is. Thanks for the outstanding referral. Am very happy in new position. - Terri
The #1 Resource for professionals in the Pharmaceutical Advertising, Medical Communications, Healthcare Public Relations, Pharmaceutical Industry, and Biotechnology fields since 1988.